Effect of ARNi (Angiotensin Receptor–Neprilysin Inhibitors) in Post Mitral Valve Replacement / Repair patients with Heart Failure: A Retrospective Analysis
DOI:
https://doi.org/10.21276/sj370795Keywords:
Mitral Valve replacement, Angiotensin receptor inhibitorAbstract
Background: Arrhythmias Induced Cardiomyopathy (AiCM) is generally a reversible condition triggered by Tachycardia, Atrial fibrillation (AF) or Premature Ventricular Contractions (PVC). The most important pillar in the Management of the AiCM remains the initiation of therapy for control of Arrhythmias (Medical management or Ablations) with the optimization of HF management
Methods: We had Seven patient of mitral valve disease who underwent open heart surgery. Post-surgery they developed signs and symptoms of heart failure along with arrhythmias (AF) and deteriorating Ejection Fraction (EF)Results: When even after optimal drug therapy their symptoms were not controlled, they were switched to ARNi from ACEi. On 6 months of therapy their symptoms improved along with their EF, QOL and arrhythmias Conclusions: So, we concluded that in these subset of patients ARNi can be tried to manage AiCM with good clinical results.
Downloads
References
Huizar JF, Ellenbogen KA, Tan AY, Kaszala K. Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(18):2328-2344. doi:10.1016/j.jacc.2019.02.045.
Rakesh Gopinathannair, Susan P. Etheridge, Francis E. Marchlinski, Francis G. Spinale, DhanunjayaLakkireddy, Brian Olshansky,Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management, Journal of the American College of Cardiology,Volume 66, Issue 15,2015,Pages 1714-1728,ISSN 0735-1097.
McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. doi:10.1056/NEJMoa1409077.
Januzzi JL Jr, Camacho A, Piña IL, et al. Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan. Circ Heart Fail. 2020;13(6):e006946. doi:10.1161/CIRCHEARTFAILURE.119.006946.
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
